PATENT CLAIM ANALYSIS

Application Number: 16176361
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "001000"]

Abstract:
Disclosed are a method for treating brain tumors, as well as a medicament for treating brain tumors. Provided is a medicament for treating brain tumors, the medicament containing a combination of 4-[4-cyano-2-({[(2′R,4S)-6-(isopropylcarbamoyl)-2,3-dihydrospiro[chromene-4,1′-cyclopropan]-2′-yl]carbonyl}amino)phenyl]butanoic acid or a pharmaceutically acceptable salt thereof, and an anti-PD-1 antibody. The combination exhibits an excellent effect for treating brain tumors, and is thus useful to treat brain tumors.

Claim (Index 19):
The method according to  claim 18 , wherein the primary brain tumor is glioma.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 97.0
- Lexical Diversity: 1.69091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15592988', '14661656', '15613192', '15510414', '15384205']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7098580706546899
- 35 USC 102 Novelty (BERT): 0.5098704285968827
- Combined Prediction Score: 0.6898593064489091
- Mean Citation Score: 248.223094
- Max Citation Score: 251.43336
- Similarity Product: 179.2899245156479

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test